---
title: "Molecular Cloning in silico"
weight: 1
---


# Molecular Cloning in silico

This chapter describes a set of tools in UGENE to perform molecular cloning experiments _in silico_.

This allows you to digest a molecule into fragments, create a fragment from a sequence region and ligate fragments into a new molecule.

*   [Digesting into Fragments](digesting-into-fragments.md)
*   [Creating Fragment](creating-fragment.md)
*   [Constructing Molecule](constructing-molecule.md)
    *   [Available Fragments](available-fragments.md)
    *   [Fragments of the New Molecule](fragments-of-the-new-molecule.md)
    *   [Changing Fragments Order in the New Molecule](changing-fragments-order-in-the-new-molecule.md)
    *   [Removing Fragment from the New Molecule](removing-fragment-from-the-new-molecule.md)
    *   [Editing Fragment Overhangs](editing-fragment-overhangs.md)
    *   [Adjusting fragment ends](adjusting-fragment-ends.md)
    *   [Reverse Complement a Fragment](reverse-complement-a-fragment.md)
    *   [Other Constuction Options](other-constuction-options.md)
    *   [Output](output.md)
*   [Creating PCR Product](creating-pcr-product.md)


-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
